3D microtumors in vitro supported by perfused vascular networks

Agua Sobrino, Duc T.T. Phan, Rupsa Datta, Xiaolin Wang, Stephanie J. Hachey, Mónica Romero-López, Enrico Gratton, Abraham P. Lee, Steven George, Christopher C.W. Hughes

Research output: Contribution to journalArticle

76 Citations (Scopus)

Abstract

There is a growing interest in developing microphysiological systems that can be used to model both normal and pathological human organs in vitro. This "organs-on-chips" approach aims to capture key structural and physiological characteristics of the target tissue. Here we describe in vitro vascularized microtumors (VMTs). This "tumor-on-a-chip" platform incorporates human tumor and stromal cells that grow in a 3D extracellular matrix and that depend for survival on nutrient delivery through living, perfused microvessels. Both colorectal and breast cancer cells grow vigorously in the platform and respond to standard-of-care therapies, showing reduced growth and/or regression. Vascular-targeting agents with different mechanisms of action can also be distinguished, and we find that drugs targeting only VEGFRs (Apatinib and Vandetanib) are not effective, whereas drugs that target VEGFRs, PDGFR and Tie2 (Linifanib and Cabozantinib) do regress the vasculature. Tumors in the VMT show strong metabolic heterogeneity when imaged using NADH Fluorescent Lifetime Imaging Microscopy and, compared to their surrounding stroma, many show a higher free/bound NADH ratio consistent with their known preference for aerobic glycolysis. The VMT platform provides a unique model for studying vascularized solid tumors in vitro.

Original languageEnglish (US)
Article number31589
JournalScientific Reports
Volume6
DOIs
StatePublished - Aug 23 2016
Externally publishedYes

Fingerprint

Blood Vessels
N-(4-(3-amino-1H-indazol-4-yl)phenyl)-N1-(2-fluoro-5-methylphenyl)urea
NAD
Neoplasms
Glycolysis
Drug Delivery Systems
Standard of Care
Stromal Cells
Microvessels
Extracellular Matrix
Microscopy
Colorectal Neoplasms
Breast Neoplasms
Food
Survival
In Vitro Techniques
Growth
Pharmaceutical Preparations
Therapeutics

ASJC Scopus subject areas

  • General

Cite this

Sobrino, A., Phan, D. T. T., Datta, R., Wang, X., Hachey, S. J., Romero-López, M., ... Hughes, C. C. W. (2016). 3D microtumors in vitro supported by perfused vascular networks. Scientific Reports, 6, [31589]. https://doi.org/10.1038/srep31589

3D microtumors in vitro supported by perfused vascular networks. / Sobrino, Agua; Phan, Duc T.T.; Datta, Rupsa; Wang, Xiaolin; Hachey, Stephanie J.; Romero-López, Mónica; Gratton, Enrico; Lee, Abraham P.; George, Steven; Hughes, Christopher C.W.

In: Scientific Reports, Vol. 6, 31589, 23.08.2016.

Research output: Contribution to journalArticle

Sobrino, A, Phan, DTT, Datta, R, Wang, X, Hachey, SJ, Romero-López, M, Gratton, E, Lee, AP, George, S & Hughes, CCW 2016, '3D microtumors in vitro supported by perfused vascular networks', Scientific Reports, vol. 6, 31589. https://doi.org/10.1038/srep31589
Sobrino A, Phan DTT, Datta R, Wang X, Hachey SJ, Romero-López M et al. 3D microtumors in vitro supported by perfused vascular networks. Scientific Reports. 2016 Aug 23;6. 31589. https://doi.org/10.1038/srep31589
Sobrino, Agua ; Phan, Duc T.T. ; Datta, Rupsa ; Wang, Xiaolin ; Hachey, Stephanie J. ; Romero-López, Mónica ; Gratton, Enrico ; Lee, Abraham P. ; George, Steven ; Hughes, Christopher C.W. / 3D microtumors in vitro supported by perfused vascular networks. In: Scientific Reports. 2016 ; Vol. 6.
@article{21a8c83043cf4b139db38c813a5a8da8,
title = "3D microtumors in vitro supported by perfused vascular networks",
abstract = "There is a growing interest in developing microphysiological systems that can be used to model both normal and pathological human organs in vitro. This {"}organs-on-chips{"} approach aims to capture key structural and physiological characteristics of the target tissue. Here we describe in vitro vascularized microtumors (VMTs). This {"}tumor-on-a-chip{"} platform incorporates human tumor and stromal cells that grow in a 3D extracellular matrix and that depend for survival on nutrient delivery through living, perfused microvessels. Both colorectal and breast cancer cells grow vigorously in the platform and respond to standard-of-care therapies, showing reduced growth and/or regression. Vascular-targeting agents with different mechanisms of action can also be distinguished, and we find that drugs targeting only VEGFRs (Apatinib and Vandetanib) are not effective, whereas drugs that target VEGFRs, PDGFR and Tie2 (Linifanib and Cabozantinib) do regress the vasculature. Tumors in the VMT show strong metabolic heterogeneity when imaged using NADH Fluorescent Lifetime Imaging Microscopy and, compared to their surrounding stroma, many show a higher free/bound NADH ratio consistent with their known preference for aerobic glycolysis. The VMT platform provides a unique model for studying vascularized solid tumors in vitro.",
author = "Agua Sobrino and Phan, {Duc T.T.} and Rupsa Datta and Xiaolin Wang and Hachey, {Stephanie J.} and M{\'o}nica Romero-L{\'o}pez and Enrico Gratton and Lee, {Abraham P.} and Steven George and Hughes, {Christopher C.W.}",
year = "2016",
month = "8",
day = "23",
doi = "10.1038/srep31589",
language = "English (US)",
volume = "6",
journal = "Scientific Reports",
issn = "2045-2322",
publisher = "Nature Publishing Group",

}

TY - JOUR

T1 - 3D microtumors in vitro supported by perfused vascular networks

AU - Sobrino, Agua

AU - Phan, Duc T.T.

AU - Datta, Rupsa

AU - Wang, Xiaolin

AU - Hachey, Stephanie J.

AU - Romero-López, Mónica

AU - Gratton, Enrico

AU - Lee, Abraham P.

AU - George, Steven

AU - Hughes, Christopher C.W.

PY - 2016/8/23

Y1 - 2016/8/23

N2 - There is a growing interest in developing microphysiological systems that can be used to model both normal and pathological human organs in vitro. This "organs-on-chips" approach aims to capture key structural and physiological characteristics of the target tissue. Here we describe in vitro vascularized microtumors (VMTs). This "tumor-on-a-chip" platform incorporates human tumor and stromal cells that grow in a 3D extracellular matrix and that depend for survival on nutrient delivery through living, perfused microvessels. Both colorectal and breast cancer cells grow vigorously in the platform and respond to standard-of-care therapies, showing reduced growth and/or regression. Vascular-targeting agents with different mechanisms of action can also be distinguished, and we find that drugs targeting only VEGFRs (Apatinib and Vandetanib) are not effective, whereas drugs that target VEGFRs, PDGFR and Tie2 (Linifanib and Cabozantinib) do regress the vasculature. Tumors in the VMT show strong metabolic heterogeneity when imaged using NADH Fluorescent Lifetime Imaging Microscopy and, compared to their surrounding stroma, many show a higher free/bound NADH ratio consistent with their known preference for aerobic glycolysis. The VMT platform provides a unique model for studying vascularized solid tumors in vitro.

AB - There is a growing interest in developing microphysiological systems that can be used to model both normal and pathological human organs in vitro. This "organs-on-chips" approach aims to capture key structural and physiological characteristics of the target tissue. Here we describe in vitro vascularized microtumors (VMTs). This "tumor-on-a-chip" platform incorporates human tumor and stromal cells that grow in a 3D extracellular matrix and that depend for survival on nutrient delivery through living, perfused microvessels. Both colorectal and breast cancer cells grow vigorously in the platform and respond to standard-of-care therapies, showing reduced growth and/or regression. Vascular-targeting agents with different mechanisms of action can also be distinguished, and we find that drugs targeting only VEGFRs (Apatinib and Vandetanib) are not effective, whereas drugs that target VEGFRs, PDGFR and Tie2 (Linifanib and Cabozantinib) do regress the vasculature. Tumors in the VMT show strong metabolic heterogeneity when imaged using NADH Fluorescent Lifetime Imaging Microscopy and, compared to their surrounding stroma, many show a higher free/bound NADH ratio consistent with their known preference for aerobic glycolysis. The VMT platform provides a unique model for studying vascularized solid tumors in vitro.

UR - http://www.scopus.com/inward/record.url?scp=84983543822&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84983543822&partnerID=8YFLogxK

U2 - 10.1038/srep31589

DO - 10.1038/srep31589

M3 - Article

C2 - 27549930

AN - SCOPUS:84983543822

VL - 6

JO - Scientific Reports

JF - Scientific Reports

SN - 2045-2322

M1 - 31589

ER -